New monitoring method could help Māori cancer patients

A simple blood test could provide a significant step to reducing health inequities for Māori cancer patients.

Professor of Biochemistry Dr Parry Guilford from the University of Otago is working on a test that would detect DNA that spills out from cancerous tumours and into the blood stream.

Professor Guilford says the test would provide a useful measure of whether or not a cancerous tumour is growing or shrinking.

“That’s important because it means that by using a simple blood test you can see whether treatment is working or not,” Professor Guilford says.

“If someone has finished treatment, you can keep an eye on them and see if it’s coming back or not.”

The DNA blood sampling method is widely used by researchers internationally, and could in principle be applied to monitor every form of cancer because they all release DNA into the blood stream.

Professor Guilford has been working to adapt the technology to New Zealand conditions, and trying to reduce the cost to make it accessible for all patients.

Among the developments are identifying a tube that is able to keep the samples stable for two weeks.

“It means that sample can go on the bus from Ruatoria and if the bus breaks down along the way, it can still be used within two weeks.

“It’s a really powerful thing.”

Professor Guilford says hospital scans and X-rays have a number of limitations, and hopes the new method would provide an earlier indication on whether the treatment is working for Māori patients.

“Those scans are only available at the bigger hospitals, which makes it tougher for Māori who live in rural parts of the country,” he says.

“That technology is also quite expensive, there’s a significant queue, and because of the radiation, you can only get them every eight to 10 weeks.”

A second trial involving non-Māori patients living in rural communities will take place at a later date.

Professor Guilford says the new method could be critical in improving health inequities facing Māori and those in isolated parts of the country.

“Whether it be rural GPs or clinics on marae, this has a real potential to take this surveillance of patients in treatment away from hospitals and out to the communities,” Professor Guilford adds.

Consultations with Māori are due to get underway in the coming weeks. Anyone interested in being involved to help develop the technology is being encouraged to contact Professor Guilford at the University’s Cancer Genetics Laboratory or by emailing parry.guilford@otago.ac.nz.